New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

Alzheimer’s disease biomarkers measured from finger-prick dried blood samples closely match standard plasma tests and predict ...

Experts discuss the underutilization of biomarker testing in metastatic lung cancer, emphasizing the need for improved ...

New potential for Alzheimer disease biomarker testing found in dried blood collection derived from capillary blood.

A new international study has demonstrated that Alzheimer's disease biomarkers can be accurately detected using simple finger ...

Blood biomarkers like p-tau217 are emerging as a way to detect Alzheimer's disease. The first FDA-approved blood-based ...

Imagine this: someone you love has just heard the words “you have cancer.” They are meeting with their oncologist – perhaps even me, or one of my colleagues – and come to understand that there is ...

Almost all of us have been touched by cancer at some point in our lives. If we haven’t had it, chances are we know a loved one or a friend who has. When someone dies from cancer, families go through ...

BeiGene is back with a new partnership and oncology campaign to raise awareness about biomarker testing for patients with chronic lymphocytic leukemia (CLL), a blood cancer marked by the ...

Obesity may quietly fast-forward Alzheimer’s disease, with blood tests revealing the change years earlier than expected.

Across all cancer types, less than 50% of patients underwent biomarker testing before first-line treatment. Many patients with advanced cancer do not receive guideline-recommended biomarker testing ...

A simple blood test can tell doctors when it is safe to stop antibiotics in patients recovering from sepsis, a review led by ...